Post by Martin King

Regulatory Affairs & Quality Assurance Expert | QA/RA Business Enabler | Medical Device, In Vitro Diagnostics, Combination Product | Navigating FDA, IVDR, MDR, PRRC | ISO Lead Auditor | [email protected]

📌 𝗧𝗵𝗲 𝗤𝗔/𝗥𝗔 𝗪𝗲𝗲𝗸 𝘁𝗵𝗮𝘁 𝗪𝗮𝘀 𝟯𝟭. 𝗠𝗮𝘆 - 𝟳. 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟲 1:27 minutes 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for the 𝟭𝟮𝟳 𝗲𝗻𝘁𝗿𝗶𝗲𝘀 from 𝟯𝟲 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗼𝗿𝘀. From 𝗘𝟲(𝗥𝟯) 𝗔𝗻𝗻𝗲𝘅 𝟮, 𝗜𝗖𝗛 𝗠𝟭𝟱, and 𝗙𝗗𝗔’𝘀 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝗱 𝗯𝗶𝗼𝗲𝗾𝘂𝗶𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝘂𝗽𝗱𝗮𝘁𝗲𝘀, to 𝗖𝗥𝗔 𝗰𝗼𝗺𝗽𝗲𝘁𝗲𝗻𝗰𝗲 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀, 𝗠𝗗𝗥 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗰𝗹𝗮𝗿𝗶𝘁𝘆, 𝗔𝗜 𝗴𝗼𝘃𝗲𝗿𝗻𝗮𝗻𝗰𝗲 𝗶𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻, 𝗣𝗩 𝘀𝘆𝘀𝘁𝗲𝗺 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴, 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗢𝗿𝗯𝗶𝘀, 𝗲𝘅𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗼𝗻𝘁𝗿𝗼𝗹𝘀, 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 𝗶𝗻𝘁𝗲𝗿𝗼𝗽𝗲𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆, and 𝗱𝘆𝗻𝗮𝗺𝗶𝗰 𝗱𝗲𝘃𝗶𝗰𝗲 𝗰𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻, the week delivered a dense set of signals that matter for anyone working in QA, RA, PV, clinical, or compliance. What stood out most is how consistently the themes converged: 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗱𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗲, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗴𝗼𝘃𝗲𝗿𝗻𝗮𝗻𝗰𝗲, 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺, 𝗰𝘆𝗯𝗲𝗿𝘀𝗲𝗰𝘂𝗿𝗶𝘁𝘆, 𝗔𝗜 𝗼𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁, 𝗮𝗻𝗱 𝘄𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝘆. 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 𝘁𝗼 𝗮𝗹𝗹 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗼𝗿𝘀: MedTech Leading Voice, Sean Smith, Martin King, BARBARA PIROLA, Bhaskar Napte ~ Pharma Coach, Marlous van der Hooft, ‫Ahmed Awad, Devin Mack, Sourabh Bansal, Steve Gompertz, Sandra Balseiro, Rabiea 🔷️ Assoc. Professor, Nataliya Nedkova, Mosaab GAYA, Marina Daineko, @Keerthi K, Joby Semmler, Galyna Cordero, Dr. Paresh Dadhaniya MVSc UKRT ERT, Dr C. Sheela Sasikumar Ph D., FSESc.,FBMS.ِِAHMD HAGAG, Hadi Danawi, PhD, MPH د. هادي ضناوي, Brian Newbery, Erik Peterich, Maurice Rouillard, Charles Rollet, Yan Kugel, @Christine Lee, Gretchen L., Danny Van Roijen, Dr. Paul R. Palmer, Aseem Bakshi, Linda Frew Shostak, Paula Andrea Pirson, Tasha Mohseni 👇 (𝘊𝘭𝘪𝘤𝘬 𝘰𝘯 𝘵𝘩𝘦 𝘢𝘳𝘵𝘪𝘤𝘭𝘦 𝘵𝘰 𝘭𝘦𝘢𝘳𝘯 𝘮𝘰𝘳𝘦) 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals